ExoZymes Inc. Files 8-K
Ticker: EXOZ · Form: 8-K · Filed: Oct 3, 2025 · CIK: 2010788
| Field | Detail |
|---|---|
| Company | Exozymes Inc. (EXOZ) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
Related Tickers: EXZ
TL;DR
EXZ filed an 8-K, mostly procedural stuff, no major news yet.
AI Summary
ExoZymes Inc. filed an 8-K on October 3, 2025, reporting on events as of September 30, 2025. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific financial figures or material events detailed in the provided text.
Why It Matters
This filing indicates ExoZymes Inc. is providing updates or submitting required financial information to the SEC, which is standard for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K submission with no disclosed material events or financial changes.
Key Players & Entities
- EXOZYMES INC. (company) — Registrant
- Invizyne Technologies Inc (company) — Former company name
- September 30, 2025 (date) — Date of earliest event reported
- October 3, 2025 (date) — Filing date
FAQ
What specific "Other Events" are being reported by ExoZymes Inc. in this 8-K?
The provided text does not specify the details of the "Other Events" reported in the 8-K.
What is the significance of the "Financial Statements and Exhibits" section in this filing?
This section indicates that ExoZymes Inc. is submitting financial statements and other exhibits as required by the SEC, but the specific content is not detailed in the provided text.
When was ExoZymes Inc. formerly known as Invizyne Technologies Inc?
The date of the name change from Invizyne Technologies Inc. to ExoZymes Inc. was February 5, 2024.
What is ExoZymes Inc.'s principal executive office address?
ExoZymes Inc.'s principal executive offices are located at 750 Royal Oaks Drive, Suite 106, Monrovia, CA 91016.
What is the SIC code for ExoZymes Inc.?
The Standard Industrial Classification (SIC) code for ExoZymes Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Stats: 385 words · 2 min read · ~1 pages · Grade level 10.4 · Accepted 2025-10-03 15:47:11
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 21KB
- ex99-1_001.jpg (GRAPHIC) — 86KB
- ex99-1_002.jpg (GRAPHIC) — 204KB
- ex99-1_003.jpg (GRAPHIC) — 166KB
- ex99-1_004.jpg (GRAPHIC) — 29KB
- ex99-1_005.jpg (GRAPHIC) — 161KB
- ex99-1_006.jpg (GRAPHIC) — 151KB
- ex99-1_007.jpg (GRAPHIC) — 131KB
- ex99-1_008.jpg (GRAPHIC) — 82KB
- ex99-1_009.jpg (GRAPHIC) — 150KB
- ex99-1_010.jpg (GRAPHIC) — 36KB
- ex99-1_011.jpg (GRAPHIC) — 126KB
- ex99-1_012.jpg (GRAPHIC) — 104KB
- ex99-1_013.jpg (GRAPHIC) — 121KB
- ex99-1_014.jpg (GRAPHIC) — 78KB
- ex99-1_015.jpg (GRAPHIC) — 53KB
- ex99-1_016.jpg (GRAPHIC) — 131KB
- ex99-1_017.jpg (GRAPHIC) — 133KB
- ex99-1_018.jpg (GRAPHIC) — 42KB
- ex99-1_019.jpg (GRAPHIC) — 89KB
- ex99-1_020.jpg (GRAPHIC) — 85KB
- ex99-1_021.jpg (GRAPHIC) — 113KB
- ex99-1_022.jpg (GRAPHIC) — 58KB
- ex99-1_023.jpg (GRAPHIC) — 61KB
- ex99-1_024.jpg (GRAPHIC) — 103KB
- ex99-1_025.jpg (GRAPHIC) — 55KB
- ex99-1_026.jpg (GRAPHIC) — 21KB
- ex99-1_027.jpg (GRAPHIC) — 125KB
- ex99-1_028.jpg (GRAPHIC) — 120KB
- ex99-1_029.jpg (GRAPHIC) — 133KB
- ex99-1_030.jpg (GRAPHIC) — 116KB
- ex99-1_031.jpg (GRAPHIC) — 154KB
- 0001493152-25-016831.txt ( ) — 4658KB
- exoz-20250930.xsd (EX-101.SCH) — 3KB
- exoz-20250930_lab.xml (EX-101.LAB) — 33KB
- exoz-20250930_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibits Description of Exhibit 99.1 Investor Presentation of eXoZymes Inc. as of September 30, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 3, 2025 EXOZYMES INC. By /s/ Fouad Nawaz Fouad Nawaz, Vice President, Finance